Status:
WITHDRAWN
Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
Lead Sponsor:
Elpen Pharmaceutical Co. Inc.
Conditions:
Anemia
Iron-deficiency
Eligibility:
All Genders
16-90 years
Brief Summary
The treatment of anemia depends on its cause. Patients with underlying iron-deficient anemia should be treated or referred to a specialist (eg gynecologist, gastroenterologist) for treatment.deficienc...
Detailed Description
The diagnosis of anemia is based on the patient's symptoms and blood tests. Blood tests refer to hemoglobin, hematocrit, and the number of red blood cells (per cubic centimeter or millet of blood). Al...
Eligibility Criteria
Inclusion
- 16-90 yers
- Iron deficiency anemia
- Treatment with iron succinylate
- Fatigue symptoms
- Informed Consent
- Compliance with study procedures
Exclusion
- Anemia caused by other parameters (non-iron-deficiency)
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03873584
Start Date
September 1 2022
End Date
September 30 2023
Last Update
February 16 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.